Literature DB >> 336446

[The effects of tolamolol on excito-conduction in men (author's transl)].

P Alboni, C Malacarne, A M Tomasi, A Masoni.   

Abstract

The electrophysiologic effects of tolamolol (UK-6558-01), a new beta-adrenergic blocking agent, were studied using the endocavitarian electrocardiography and the extrastimulus method. The drug was infused intravenously in the dose of 20 mg (0,23-0,36 mg per kilogram). Tolamolol resulted in: -- prolongation of sinus cycle length in 17 patients (P less than 0.001); -- prolongation of correct sinus node recovery time in 16 patients (P less than 0.001); -- there was no significant modification in intra-atrial conduction (P less than 0.3), while atrail effective refractory period was slightly lengthened (P less than 0.03); -- in A-V node conduction was prolonged in 17 patients (P less than 0.001) and the effective functional refractory periods were prolonged in all patients (P less than 0.001); -- a A-V block of 2 degrees grade appears in 17 patients at a more prolonged cycle length (P less than 0.001). Tolamolol had no effect on His-Purkinje system conduction time as well as the relative refractory period, measured before and after the drug in 2 patients. In 6 patients, during the induction of extrastimuli an "echo zone" appeared; after tolamolol its duration was reduced in 4 patients, in one unchanged and in one abolished. The therapeutical properties of this drug are discussed on the basis of such experimental data.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 336446

Source DB:  PubMed          Journal:  G Ital Cardiol        ISSN: 0046-5968


  1 in total

1.  Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.

Authors:  V Hombach; V Braun; H W Höpp; D Gil-Sanchez; D W Behrenbeck; M Tauchert; H H Hilger
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.